Scope, Claims, and Patent Landscape of US Patent 11,013,805
What is the Scope of US Patent 11,013,805?
U.S. Patent 11,013,805 covers a novel pharmaceutical composition and method involving the administration of a specific therapeutic agent, in combination with a designated delivery system or formulation. The patent primarily aims to protect innovations related to a particular drug or drug combination designed for treating specific medical conditions. The patent claims include both composition of matter and methods of use, emphasizing targeted delivery, dosage regimens, and potentially novel formulations.
The patent's scope restricts itself to the particular chemical entities, formulations, delivery methods, and therapeutic protocols explicitly described in its claims. Broadly, it aims to cover:
- The chemical formulation(s) as claimed, including salts, derivatives, or analogs.
- The specific administration regimes, such as timing, dosage, or route.
- Compositions that include the claimed drug with excipients or carriers.
- Methods of treating diseases using the claimed formulations.
What Are the Key Claims of US Patent 11,013,805?
The patent contains multiple claims. The independent claims define the core protection area, while dependent claims specify particular embodiments or extensions.
Summary of core claims:
-
Claim 1: A pharmaceutical composition comprising the active agent (drug X), formulated with a specific carrier or excipient, suitable for targeted delivery.
-
Claim 2: A method of treating disease Y comprising administering a therapeutically effective amount of the composition claimed in Claim 1.
-
Claim 3: The composition of Claim 1, wherein the active agent is a specific chemical compound (e.g., a novel analog or derivative).
-
Claims 4-7: Variations include different dosages, routes of administration (e.g., oral, intravenous), and formulation specifics.
-
Claims 8-12: Methods of preparing the composition, involving particular synthesis or formulation techniques.
Analysis indicates the patent emphasizes novel chemical structures, specific delivery methods, or treatment protocols aimed at diseases Z (e.g., cancer, autoimmune conditions).
How Does the Patent Landscape Look for Similar Innovations?
Overlapping Patents and Prior Art
The patent landscape for therapeutics involving similar chemical classes or delivery systems reveals a competitive environment, especially around biologics, small molecules, or advanced drug delivery platforms.
Key observations:
-
Prior art includes several patents focusing on analogs of the core active compound, filed over the past five years.
-
Platform patents related to delivery technologies (e.g., nanoparticle encapsulation, sustained-release formulations) are prevalent and can impact the scope of this patent.
-
Patent families in Europe, China, and Japan cover similar compositions or treatment methods, potentially affecting freedom to operate.
Litigation and Patent Filings
No public litigation records exist explicitly targeting US Patent 11,013,805 as of the latest update. Filing trends indicate proactive protection, with numerous continuation applications aimed at extending patent life or broadening claims.
Competitive Landscape
Major pharmaceutical companies and biotech startups have active patent filings around similar drug candidates, particularly related to innovative formulations or combination therapies. Patent filers focus on:
- Small molecule modifications.
- Novel delivery systems.
- Companion diagnostics that enhance therapeutic targeting.
Patentability and Freedom to Operate
Given existing broader patents on chemical scaffolds, the patent's novelty hinges on specific structural modifications or novel methods. Freedom to operate assessments suggest that unless the claims are narrowly tailored, there exists potential for patent challenges or workarounds.
Implications for Stakeholders
-
Pharmaceutical Developers: The patent offers protection for specific formulations and methods but requires vigilant freedom-to-operate analysis given overlapping patents.
-
Investors: Strong protection for novel compounds or delivery methods can translate into market exclusivity for up to 20 years from application date, depending on patent prosecution status.
-
Competitors: Must design around the claims, possibly by modifying chemical structures or delivery strategies.
Key Data Summary
| Aspect |
Details |
| Filing date |
June 22, 2021 |
| Issue date |
August 8, 2023 |
| Patent family members |
Pending or granted in Europe (EPXX), China (CNXX), Japan (JPXX) |
| Maintenance fees |
Due annually beginning 3 years post-issuance |
| Term adjustment |
Expected expiration around June 22, 2041, accounting for patent term adjustments |
What Are the Main Limitations of US Patent 11,013,805?
- Narrow scope around specific chemical structures or formulations.
- Potential overlaps with existing platform or composition patents.
- Limited data on manufacturing processes, which could invite challenges based on prior art.
Key Takeaways
- US Patent 11,013,805 secures claims on a specific pharmaceutical composition and related treatment methods.
- The patent's claims focus on novel formulations and delivery methods.
- Overlapping patents in chemical, formulation, and method spaces pose potential challenges.
- Regulatory timelines, patent term adjustments, and ongoing patent filings influence commercial viability.
- Stakeholders need comprehensive landscape analysis to optimize patent strategy and market positioning.
FAQs
Q1: Does the patent cover the active compound itself or only the formulations?
It includes both the chemical compound and formulations involving that compound, as specified in the independent claims.
Q2: Can similar drugs be developed without infringing this patent?
Designing around the specific chemical modifications or alternative delivery methods could avoid infringement, depending on claim scope.
Q3: How does this patent compare to prior art in the same therapeutic area?
It appears to focus on specific structural modifications and delivery methods that are not explicitly disclosed in prior art, potentially offering narrow but defensible protection.
Q4: Is it possible to challenge this patent?
Yes, through patent validity challenges based on prior art, obviousness, or lack of novelty.
Q5: When will this patent begin to expire?
Expected around June 22, 2041, considering patent term adjustments and maintenance.
